Information
-
Trademark
-
79330277
-
Serial Number
79330277
-
Registration Number
7141193
-
International Classifications
-
Filing Date
November 17, 2021
4 years ago
-
Registration Date
August 22, 2023
2 years ago
-
Transaction Date
December 11, 2023
2 years ago
-
Status Date
August 22, 2023
2 years ago
-
Published for Opposition Date
June 06, 2023
2 years ago
-
Location Date
August 22, 2023
2 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
KLUWE, CHERYL D
-
Attorney Docket Number
BrightIP235
Attorney Name
Timothy T. Wang
Law Office Assigned Location Code
N80
-
Owners
Mark Drawing Code
3000
Mark Identification
GP GETEIN BIOTECH, INC.
Case File Statements
- DM0000: The mark consists of the wording "GP GETEIN BIOTECH, INC.", "GP" formed by horizontal lines and appearing to the left of "GETEIN BIOTECH, INC.".
- GS0051: Medicines for human purposes, namely, medicines for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; biological preparations for medical purposes, namely, preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; diagnostic preparations for medical purposes; biochemical preparations for medical use, namely, preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Medicated serums for treatment of viral infections, diseases of the blood system, diseases of the immune system, skin diseases, diseases caused by bacterial exotoxins, bacterial infections, fungal infections, parasitic infections; chemical preparations for medical purposes, namely, for cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Drugs for medical purposes for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Pharmaceutical preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; vaccines; dietetic substances adapted for medical use
- TR0010: The wording "GETEIN" has no meaning in a foreign language.
- GS0101: Diagnostic testing apparatus for testing blood sugar levels, cancer cells, DNA, sugars, hormones, enzymes, lipids, vitamins, inorganic ions, electrolytes, drugs and drug metabolites, autoantibodies, proteins, microorganisms, Drug allergy, allergens, antigens of pathogenic pathogens, antibodies of pathogenic pathogens and nucleic acids of pathogenic pathogens, blood type, tissue type, human genes, hereditary diseases, biochemical indicators, immune function indicators, narcotics, psychotropic drugs, Toxic drugs for medical use, therapeutic drug targets, tumor markers for medical purposes; diagnostic apparatus for use in medical analysis of blood; surgical apparatus and instruments; blood testing apparatus; galvanic therapeutic appliances for wound healing; Diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells, DNA, sugars, hormones, enzymes, lipids, vitamins, inorganic ions, electrolytes, drugs and drug metabolites, autoantibodies, proteins, microorganisms, Drug allergy, allergens, antigens of pathogenic pathogens, antibodies of pathogenic pathogens and nucleic acids of pathogenic pathogens, blood type, tissue type, human genes, hereditary diseases, biochemical indicators, immune function indicators, narcotics, psychotropic drugs, Toxic drugs for medical use, therapeutic drug targets, tumor markers; Medical apparatus and instruments, namely, for cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases diagnosis; urological apparatus and instruments for surgery, diagnostic testing, treatment, adjuvant therapy; X-ray apparatus for medical purposes
- D10000: "BIOTECH, INC."
Case File Event Statements
-
12/11/2023 - 2 years ago
32 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
11/22/2023 - 2 years ago
31 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
11/22/2023 - 2 years ago
30 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
11/22/2023 - 2 years ago
29 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
8/22/2023 - 2 years ago
28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC
-
8/22/2023 - 2 years ago
27 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
6/25/2023 - 2 years ago
26 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Type: OPNX
-
6/7/2023 - 2 years ago
25 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
6/7/2023 - 2 years ago
24 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Type: OPNR
-
6/6/2023 - 2 years ago
23 - NOTIFICATION PROCESSED BY IB
Type: GPNX
-
6/6/2023 - 2 years ago
22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/6/2023 - 2 years ago
21 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
5/17/2023 - 2 years ago
20 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
5/17/2023 - 2 years ago
19 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Type: OP2R
-
5/17/2023 - 2 years ago
18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/4/2023 - 2 years ago
17 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/4/2023 - 2 years ago
16 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
5/4/2023 - 2 years ago
15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
5/4/2023 - 2 years ago
14 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
5/4/2023 - 2 years ago
13 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
4/27/2023 - 2 years ago
12 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
4/27/2023 - 2 years ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
4/27/2023 - 2 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
11/21/2022 - 3 years ago
9 - REFUSAL PROCESSED BY IB
Type: RFNT
-
11/3/2022 - 3 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
11/3/2022 - 3 years ago
7 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
9/10/2022 - 3 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
9/9/2022 - 3 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
8/29/2022 - 3 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
1/11/2022 - 4 years ago
3 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
1/7/2022 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
1/6/2022 - 4 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR